These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 378352)

  • 21. Localisation of Ca and HMFG2 antigens in breast tissue by immunoperoxidase, immunofluorescence, and immunoelectron microscopy.
    Beckford U; Barbatis C; Beesley JE; Linsell JC; Chantler SM
    J Clin Pathol; 1985 May; 38(5):512-20. PubMed ID: 3889068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study.
    Gill S; Peston D; Vonderhaar BK; Shousha S
    J Clin Pathol; 2001 Dec; 54(12):956-60. PubMed ID: 11729217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An immunohistological study of monoclonal antibody BG6 against human breast cancer].
    Zhang SL
    Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):59-61. PubMed ID: 2550156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L; Sarcević B; Malenica B; Novak D
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vimentin expression in benign and malignant breast epithelium.
    Heatley M; Whiteside C; Maxwell P; Toner P
    J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A monoclonal antibody (AB/3) reactive with human breast cancer.
    Iacobelli S; Natoli V; Scambia G; Santeusanio G; Negrini R; Natoli C
    Cancer Res; 1985 Sep; 45(9):4334-8. PubMed ID: 3896478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CEA and NCA in benign and malignant breast tumors.
    Nap M; Keuning H; Burtin P; Oosterhuis JW; Fleuren G
    Am J Clin Pathol; 1984 Nov; 82(5):526-34. PubMed ID: 6388310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of CA-50 radioimmunoassay inhibition test in the differential diagnosis of benign and malignant breast disease.
    Hershman MJ; Habib NA; Kelly SB; Beynon J; Williamson RC; Davies PW; Wood CB
    Eur J Surg Oncol; 1988 Oct; 14(5):413-5. PubMed ID: 3181445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium.
    Vowden P; Lowe AD; Lennox ES; Bleehen NM
    Br J Cancer; 1986 Mar; 53(3):313-9. PubMed ID: 3516191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies 323/A3 and Ca1 identify a paracrine function of breast carcinoma on adjacent benign histological components.
    Courtney SP; Williams S; Mansel RE
    Br J Cancer Suppl; 1990 Jul; 10():92-5. PubMed ID: 1696492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours.
    Bartek J; Taylor-Papadimitriou J; Miller N; Millis R
    Int J Cancer; 1985 Sep; 36(3):299-306. PubMed ID: 2411673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma.
    Holder WD; Wells SA
    Cancer Res; 1983 Jan; 43(1):239-44. PubMed ID: 6291754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of a totally human monoclonal antibody for the staining of primary and metastatic human breast tumors.
    Strelkauskas AJ; Welsh J; Metcalf JS; Aldenderfer PH
    Hum Antibodies Hybridomas; 1994; 5(3-4):157-64. PubMed ID: 7756580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and immunohistological characterization of human monoclonal antibodies to mammary carcinoma cells.
    Imam A; Drushella MM; Taylor CR; Tökés ZA
    Cancer Res; 1985 Jan; 45(1):263-71. PubMed ID: 2578096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical and immunological characterizations of antigens recognised by human monoclonal antibodies.
    Imam A; Taylor CR
    Br J Cancer; 1989 Jun; 59(6):922-8. PubMed ID: 2472167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of isopeptide bonds N epsilon (gamma-glutamyl) lysine in benign and malignant human breast lesions: an immunohistochemical study.
    Roch AM; Noel P; el Alaoui S; Charlot C; Quash G
    Int J Cancer; 1991 May; 48(2):215-20. PubMed ID: 1673451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical investigation of the Oxford tumour marker Ca1 in the histological diagnosis of breast cancer and pre-cancer.
    Simpson HW; Candlish W; Liddle C; McGregor M; Mutch F; Tinkler B
    Histopathology; 1984 May; 8(3):481-99. PubMed ID: 6376326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection by a human monoclonal antibody of a glycoprotein associated with malignant proliferation of mammary epithelial cells.
    Imam SA; Mills LA; Taylor CR
    Br J Cancer; 1991 Dec; 64(6):1001-10. PubMed ID: 1662531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.